Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - South Africa

South Africa

In South Africa, the Treatment of Cardiovascular Diseases market is predicted to achieve a revenue of US$1.54bn in 2024.
Furthermore, it is anticipated that the revenue will experience an annual growth rate of 2.94% between 2024 and 2029, ultimately leading to a market volume of US$1.78bn by 2029.
When comparing these figures to other countries worldwide, it is noteworthy that in the United States will generate the highest revenue of US$136.00bn in 2024.
In South Africa, there is a growing trend towards the use of telemedicine for remote monitoring and management of cardiovascular diseases.

Key regions: China, India, United States, France, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.